Resona Asset Management Co. Ltd. Has $19.73 Million Stock Position in Cardinal Health, Inc. $CAH

Resona Asset Management Co. Ltd. decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 6.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 95,769 shares of the company’s stock after selling 6,539 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Cardinal Health were worth $19,727,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Redhawk Wealth Advisors Inc. boosted its position in Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after purchasing an additional 48 shares during the last quarter. HF Advisory Group LLC boosted its position in Cardinal Health by 0.9% during the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after purchasing an additional 49 shares during the last quarter. Generali Asset Management SPA SGR boosted its position in Cardinal Health by 11.0% during the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after purchasing an additional 51 shares during the last quarter. Stephens Inc. AR boosted its position in Cardinal Health by 0.9% during the fourth quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock valued at $1,223,000 after purchasing an additional 52 shares during the last quarter. Finally, Latitude Advisors LLC boosted its position in Cardinal Health by 2.1% during the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock valued at $408,000 after purchasing an additional 53 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $200.31 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The business has a 50-day moving average of $206.29 and a two-hundred day moving average of $208.61. The stock has a market capitalization of $46.91 billion, a P/E ratio of 30.63, a P/E/G ratio of 1.19 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 31.19%.

Analyst Ratings Changes

A number of analysts have weighed in on CAH shares. Weiss Ratings raised Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday, May 4th. Barclays boosted their price target on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Wells Fargo & Company reduced their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. JPMorgan Chase & Co. reduced their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. Finally, William Blair started coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.